SupplementDrug
Withanolide D clinical trials
- studies test it
- 3
- open now
- 0
- in phase 3
- 0
- first study started
- 2021
How studies write it
Studies that test it under each name
Combined with it in one product
Studies by the year they started
3 studies that test it; most in 2021 (1)
| Year | Studies |
|---|---|
| 2021 | 1 |
| 2023 | 1 |
| 2025 | 1 |
By phase
A phase 1/2 study counts in both.
- Phase 2
- 1
- No phase
- 2
What it is tested for
Each study’s main condition, where its own words name it.
Who runs them
Industry 0 · Other 3
Medical University of Lodz (1) · Ivan Luzardo-Ocampo (1) · Sunnybrook Health Sciences Centre (1)
Often tested with
Tested in the same studies.
Studies
Open first, then newest update. How each study uses withanolide D is read from its arms, and is right about nine times in ten.
Testing it · 3
- The Effect of Standardized Withania Somnifera Extract on Endocrine, Metabolic, and Psychometric Parameters, in Women With Polyendocrine Metabolic Ovarian SyndromeCompletedNot applicableMedical University of LodzNCT07750899Written as Withania somnifera
- Impact of Ashwagandha in Obesity Parameters from Mexican AdultsCompletedNot applicableIvan Luzardo-OcampoNCT06676605Written as Withania somnifera
- NF-κB Inhibition in Amyotrophic Lateral SclerosisStatus unknownPhase 2Sunnybrook Health Sciences CentreNCT05031351Written as Withania somnifera
Given in every arm · 1 — withanolide D is usual care beside what is tested
Codes
What other systems call withanolide D · ClinicalTrials.gg INT018515
| System | Code | Name there | Checked by |
|---|---|---|---|
| RxNorm | 2604033 | — | One source FDA |
| Wikidata | Q27089384 | withanolide D | One source Wikidata |
“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.